Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation

被引:27
作者
Arighi, Andrea [1 ]
Arcaro, Marina [1 ]
Fumagalli, Giorgio Giulio [1 ]
Carandini, Tiziana [1 ]
Pietroboni, Anna Margherita [1 ]
Sacchi, Luca [1 ,2 ]
Fenoglio, Chiara [2 ]
Serpente, Maria [1 ]
Sorrentino, Federica [2 ]
Isgro, Giovanni [1 ]
Turkheimer, Federico [3 ]
Scarpini, Elio [1 ,2 ]
Galimberti, Daniela [1 ,2 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurodegenerat Dis Unit, Via Francesco Sforza 35, I-20122 Milan, Italy
[2] Univ Milan, Milan, Italy
[3] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London, England
关键词
Glymphatic system; Aquaporin; 4; Amyloid-beta; Cerebrospinal fluid; Alzheimer's disease; Frontotemporal dementia; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; PREVALENCE; PATHOLOGY;
D O I
10.1186/s13195-022-01077-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aquaporin-4 (AQP4) is a channel protein that plays a fundamental role in glymphatic system, a newly described pathway for fluid exchange in the central nervous system, as well as a central figure in a fascinating new theory for the pathophysiology of neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD). In this study, cerebrospinal fluid (CSF) concentration of AQP4, amyloid-beta, total tau and P-tau were determined in 103 CSF samples from patients affected by neurodegenerative dementias (AD and FTD) or psychiatric diseases and 21 controls. Significantly higher levels of AQP4 were found in AD and FTD patients compared to subjects not affected by neurodegenerative diseases, and a significant, positive correlation between AQP4 and total tau levels was found. This evidence may pave the way for future studies focused on the role of this channel protein in the clinical assessment of the glymphatic function and degree of neurodegeneration.
引用
收藏
页数:10
相关论文
共 39 条
  • [1] American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, V5th
  • [2] Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
    Arighi, Andrea
    Di Cristofori, Andrea
    Fenoglio, Chiara
    Borsa, Stefano
    D'Anca, Marianna
    Fumagalli, Giorgio Giulio
    Locatelli, Marco
    Carrabba, Giorgio
    Pietroboni, Anna Margherita
    Ghezzi, Laura
    Carandini, Tiziana
    Colombi, Annalisa
    Scarioni, Marta
    De Riz, Milena Alessandra
    Serpente, Maria
    Rampini, Paolo Maria
    Scarpini, Elio
    Galimberti, Daniela
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (03) : 663 - 669
  • [3] Evaluation of DSM-5 and IWG-2 criteria for the diagnosis of Alzheimer's disease and dementia with Lewy bodies
    Baker, Kerry G.
    [J]. DIAGNOSIS, 2016, 3 (01) : 9 - 12
  • [4] Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease
    Bergstrom, Sofia
    Remnestal, Julia
    Yousef, Jamil
    Olofsson, Jennie
    Markaki, Ioanna
    Carvalho, Stephanie
    Corvol, Jean-Christophe
    Kultima, Kim
    Kilander, Lena
    Lowenmark, Malin
    Ingelsson, Martin
    Blennow, Kaj
    Zetterberg, Henrik
    Nellgard, Bengt
    Brosseron, Frederic
    Heneka, Michael T.
    Bosch, Beatriz
    Sanchez-Valle, Raquel
    Manberg, Anna
    Svenningsson, Per
    Nilsson, Peter
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (07): : 1456 - 1470
  • [5] Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 3 - 23
  • [6] Understanding the role of the perivascular space in cerebral small vessel disease
    Brown, Rosalind
    Benveniste, Helene
    Black, Sandra E.
    Charpak, Serge
    Dichgans, Martin
    Joutel, Anne
    Nedergaard, Maiken
    Smith, Kenneth J.
    Zlokovic, Berislav V.
    Wardlaw, Joanna M.
    [J]. CARDIOVASCULAR RESEARCH, 2018, 114 (11) : 1462 - 1473
  • [7] Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes
    Coyle-Gilchrist, Ian T. S.
    Dick, Katrina M.
    Patterson, Karalyn
    Rodriquez, Patricia Vazquez
    Wehmann, Eileen
    Wilcox, Alicia
    Lansdall, Claire J.
    Dawson, Kate E.
    Wiggins, Julie
    Mead, Simon
    Brayne, Carol
    Rowe, James B.
    [J]. NEUROLOGY, 2016, 86 (18) : 1736 - 1743
  • [8] Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
    Dubois, Bruno
    Feldman, Howard H.
    Jacova, Claudia
    Hampel, Harald
    Molinuevo, Jose Luis
    Blennow, Kaj
    Dekosky, Steven T.
    Gauthier, Serge
    Selkoe, Dennis
    Bateman, Randall
    Cappa, Stefano
    Crutch, Sebastian
    Engelborghs, Sebastiaan
    Frisoni, Giovanni B.
    Fox, Nick C.
    Galasko, Douglas
    Habert, Marie-Odile
    Jicha, Gregory A.
    Nordberg, Agneta
    Pasquier, Florence
    Rabinovici, Gil
    Robert, Philippe
    Rowe, Christopher
    Salloway, Stephen
    Sarazin, Marie
    Epelbaum, Stephane
    de Souza, Leonardo C.
    Vellas, Bruno
    Visser, Pieter J.
    Schneider, Lon
    Stern, Yaakov
    Scheltens, Philip
    Cummings, Jeffrey L.
    [J]. LANCET NEUROLOGY, 2014, 13 (06) : 614 - 629
  • [9] CLEIA CA125 evidences: good analytical performance avoiding "Hook effect"
    Falzarano, R.
    Viggiani, V.
    Michienzi, S.
    Colaprisca, B.
    Longo, F.
    Frati, L.
    Anastasi, E.
    [J]. TUMOR BIOLOGY, 2013, 34 (01) : 387 - 393
  • [10] Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia
    Graham, Neil S. N.
    Sharp, David J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (11) : 1221 - 1233